- Report
- February 2024
- 115 Pages
Global
From €4539EUR$4,750USD£3,862GBP
- Report
- February 2024
- 170 Pages
Global
From €4683EUR$4,900USD£3,984GBP
- Report
- October 2023
- 189 Pages
Global
From €4683EUR$4,900USD£3,984GBP
- Report
- October 2023
- 177 Pages
Global
From €4683EUR$4,900USD£3,984GBP
- Report
- October 2023
- 171 Pages
Global
From €4683EUR$4,900USD£3,984GBP
- Report
- October 2023
- 150 Pages
Global
From €4635EUR$4,850USD£3,944GBP
- Report
- August 2023
- 188 Pages
Global
From €3044EUR$3,185USD£2,590GBP
€4348EUR$4,550USD£3,700GBP
- Report
- February 2024
- 115 Pages
Global
From €4539EUR$4,750USD£3,862GBP
- Report
- May 2024
- 182 Pages
Global
From €4683EUR$4,900USD£3,984GBP
- Report
- April 2024
- 181 Pages
Global
From €4683EUR$4,900USD£3,984GBP
- Report
- April 2024
- 180 Pages
Global
From €4683EUR$4,900USD£3,984GBP
- Report
- April 2024
- 185 Pages
Global
From €4683EUR$4,900USD£3,984GBP
- Report
- January 2024
- 188 Pages
Global
From €4683EUR$4,900USD£3,984GBP
- Report
- January 2024
- 175 Pages
Global
From €4683EUR$4,900USD£3,984GBP
- Report
- January 2024
- 175 Pages
Global
From €4683EUR$4,900USD£3,984GBP
- Report
- September 2023
- 172 Pages
Global
From €2389EUR$2,500USD£2,033GBP
- Report
- August 2023
- 157 Pages
Global
From €2389EUR$2,500USD£2,033GBP
- Report
- November 2023
- 113 Pages
Global
From €7167EUR$7,500USD£6,098GBP
- Report
- April 2024
- 188 Pages
Global
From €4683EUR$4,900USD£3,984GBP
- Report
- January 2024
- 189 Pages
Global
From €4683EUR$4,900USD£3,984GBP
The Eye Disease market within the Optical industry is a rapidly growing sector, with a focus on providing treatments and solutions for a variety of eye conditions. This includes the diagnosis and management of conditions such as glaucoma, cataracts, macular degeneration, and diabetic retinopathy. Companies in this market are developing innovative technologies to improve the accuracy and speed of diagnosis, as well as treatments to improve patient outcomes.
The Eye Disease market is also focused on providing solutions to improve patient access to care, such as telemedicine and remote monitoring. This is helping to reduce the burden on healthcare systems and improve patient outcomes.
Companies in the Eye Disease market include Alcon, Bausch + Lomb, Carl Zeiss Meditec, Essilor, Hoya, Johnson & Johnson Vision, Novartis, and Topcon. Show Less Read more